Key Performance Index
This is general content for the Key Performance Index. The KPIs of the various monitoring studies are shown below automatically
The number of women and men who received an invitation for breast, cervical or bowel cancer screening in 2021.
The number of women and men who participated in breast, cervical or bowel cancer screening in 2021.
In the Netherlands 950 staff were involved in carrying out the three cancer screening programs that took place in 2020.
The number of people diagnosed with cancer following the health screening program in 2021.
The number of women who received an invitation in 2021.
In addition to the measures due to COVID-19, the shortage of staff in the screening also played a role in the delay in inviting.
In 2021, 885.937 women participated in the breast cancer population screening. This is 72,5% of all women invited.
The turnout rate may be lower in 2021 due to fears of COVID-19, despite the precautions taken in the screening units to keep their distance.
71 screening centres
There are 71 screening centres in the Netherlands; 58 mobile and 13 permanent. The aim of the mobile screening centres is to offer the screening as close to home as possible.
Of every 1,000 women participating in the study, 26 are referred for further examination in the hospital. The population screening detected 6,362 cases of breast cancer in 2021.
The number of women who received an invitation in 2021 for the cervical cancer screening program.
The number of women who participated in the cervical cancer screening program in 2021 with a smear (42,7%) or self-sampling kit (12,1%).
Of the number of women who participated in the cervical cancer screening program in 2021, HPV was found in 9,5%.
The number of diagnoses of (precancerous) cervical cancer in 2021. This is 1.1% of all participants.
The number of men and women who received an invitation in 2021 for the colon cancer screening program.
The number of men and women who participated in the colon cancer screening program in 2021.
The number of clients who were referred to the hospital in 2021 following their participation in the colon cancer screening program. This is 4,6%.
2.790x colon cancer found
A total of 2.790 colon cancers and 16.878 advanced adenomas were found among the participants invited in 2021.